Head-to-head · WeighScore
TeleDocs360 vs WeightCare
By GLP-1 ScorecardUpdated
Score comparison
TeleDocs360 has the higher recorded score — 55.2/100 to 52.2/100.
TeleDocs360 grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleDocs360 is a cash-pay telehealth service offering compounded GLP-1 weight loss medications, including injectable semaglutide and tirzepatide, oral semaglutide, plus phentermine and NAD+ therapy.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | TeleDocs360 | WeightCare |
|---|---|---|
| WeighScore | 55.2/100 | 52.2/100 |
| Grade | C | C |
| Site position | #492 | #522 |
| Semaglutide | $399/mo (compounded) | $399/mo |
| Tirzepatide | $399/mo (compounded) | $499/mo (15 mg dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Not confirmed |
Site position #492 · C
Strengths
- Transparent $399/month base pricing for standard dosing
- Multiple GLP-1 options including injectable and oral semaglutide
- Cash-pay model with HSA/FSA card acceptance
- Fast online intake and 24-hour prescription approval
- Cancel anytime between shipments
What to consider
- Compounded-only; no FDA-approved branded options
- No published state availability list
- No individual provider credentials or board certifications shown
- Higher doses increase cost
Site position #522 · C
FDAWarning letter issued to Weightless Medical LLC dba WeightCare in February 2026. See the FDA warning-letter database.
Strengths
- PCAB-accredited pharmacy partners — strongest pharmacy quality signal
- Quality testing: potency and sterility per USP 797 standards
- 85,000+ members since 2022 — established patient base
- Multiple program tiers for semaglutide
- Health coaching, dietitians, fitness trainers included
What to consider
- No LegitScript certification on the site itself
- State availability not explicitly listed
- Compounded only — no brand-name options
- Semaglutide runs $215-$399/mo and tirzepatide $275-$499/mo depending on plan length and dose
- FDA issued Weightless Medical LLC dba WeightCare a warning letter in February 2026; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.